A High-Throughput Yellow Fever Neutralization Assay-Reference-Cited by-同舟云学术

A High-Throughput Yellow Fever Neutralization Assay

Published:2022-06-29 Issue:3 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Rasulova Madina¹²^ORCID,Vercruysse Thomas¹²,Paulissen Jasmine¹²,Coun Catherina¹²,Suin Vanessa³,Heyndrickx Leo⁴,Ma Ji¹⁵,Geerts Katrien¹⁵,Timmermans Jolien¹²,Mishra Niraj¹⁵,Li Li-Hsin¹⁵,Kum Dieudonné Buh¹⁵,Coelmont Lotte¹⁵,Van Gucht Steven³,Karimzadeh Hadi⁶⁷,Thorn-Seshold Julia⁶⁷,Rothenfußer Simon⁶⁷,Ariën Kevin K.⁴⁸,Neyts Johan¹⁵,Dallmeier Kai¹⁵^ORCID,Thibaut Hendrik Jan¹²^ORCID

Affiliation:

1. KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium

2. KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), Leuven, Belgium

3. Sciensano, Viral Diseases Service, Scientific Directorate of Infectious Diseases in Humans, Brussels, Belgium

4. Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium

5. Global Virus Network (GVN), Baltimore, Maryland, USA

6. Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany

7. Unit Clinical Pharmacology (EKliP), Helmholtz Center for Environmental Health, Munich, Germany

8. Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium

Abstract

Fast and accurate detection of neutralizing antibodies (nAbs) against yellow fever virus (YFV) is key in yellow fever serodiagnosis, outbreak surveillance, and monitoring of vaccine efficacy. Although classical PRNT remains the gold standard for measuring YFV nAbs, this methodology suffers from inherent limitations such as low throughput and overall high labor intensity.

Funder

Fonds Wetenschappelijk Onderzoek

European Union

KU Leuven

German research foundation

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02548-21

Reference46 articles.

1. World Health Organization. 2019. Yellow fever. https://www.who.int/news-room/fact-sheets/detail/yellow-fever#:~:text=Yellow%20fever%20is%20an%20acute %2C%20nausea%2C%20vomiting%20and%20fatigue. Retrieved 2 November 2021.

2. Pathogenic flaviviruses

3. Lindenbach B, Thiel HJ, Rice CM. 2007. Flaviviridae: the viruses and their replication, p 1101–1151. In Knipe DM, Howley PM (ed), Fields virology, 5th ed. Wolters Kluwer Health, Lippincott Williams & Wilkins, Philadelphia, PA.

4. THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION

5. Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017–2018 sylvatic outbreak in Brazil;Microbiology Spectrum;2024-05-02

2. Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis and meta-regression;Journal of Travel Medicine;2024-03-04

3. Multiplexed multicolor antiviral assay amenable for high-throughput research;Nature Communications;2024-01-02

4. SeParate: multiway fluorescence-activated droplet sorting based on integration of serial and parallel triaging concepts;Lab on a Chip;2024

5. Detergent-free parasite transformation and replication assay for drug screening against intracellular Leishmania amastigotes;Journal of Microbiological Methods;2023-12